This is Hamamoto from TIMEWELL.
The startup environment demands constant adaptation. Markets shift. Technology outpaces plans. Regulatory environments create unexpected constraints. And through all of it, the people at the top have to make fast decisions with incomplete information.
Michael Mager, CEO of Precision Neuroscience — a company developing brain-computer interface technology — has built an organization at the intersection of neuroscience, engineering, and medical device regulation. His experience offers a concrete, ground-level view of what startup leadership actually requires: how to hire, how to raise money, how to manage KPIs, and how to stay functional as a leader when everything is on fire.
The CEO's Job: Hiring Around Mission
Why Hiring Is the First Discipline
Mager is direct about this: the quality of the team is the quality of the company. Not the technology, not the product roadmap, not the investor list — the team. And the primary criterion for hiring, in his view, is not just skill and technical fit but genuine commitment to the mission.
The logic is that a startup will inevitably face periods of difficulty — when the market doesn't respond as expected, when a key assumption turns out to be wrong, when funding gets harder. In those moments, what holds a team together is not compensation or equity value (which may be temporarily zero) but conviction that the work matters. Hiring for that conviction is harder to measure than skills assessment, but it is more predictive of what happens under real pressure.
Key hiring criteria at mission-driven startups:
- Demonstrated alignment with the core mission, not just interest in the role
- CEO-level leadership that articulates and embodies the mission consistently
- Rapid decision-making ability — startups cannot afford the deliberation pace of large organizations
- HR function treated as foundational, not administrative overhead
The Path to the CEO Role
Mager notes that there are multiple legitimate paths: MBA programs, corporate leadership development, years of steady advancement inside an organization. But for founders who build from scratch, the irreplaceable training is the experience itself. "Action and the willingness to take risk" — these are skills that cannot be acquired in a classroom or simulated in a training program.
The CEO as Bottleneck — and How to Avoid It
Mager is candid about a mistake he made early: trying to respond to every email, solve every problem personally, be everywhere at once. The result was that he became the bottleneck in his own organization. Every decision waited on him. Every fire required his presence.
The discipline he developed was triage: not every email needs an immediate response, not every problem requires the CEO's direct involvement. Distinguishing between what genuinely requires the top of the organization and what can be handled at the level where it arises is, he suggests, one of the most important operating habits a startup CEO can build.
Looking for AI training and consulting?
Learn about WARP training programs and consulting services in our materials.
Fundraising and Valuation: What the Numbers Actually Mean
Staged Fundraising and Dilution Management
Precision Neuroscience has raised capital through multiple rounds — Series A, Series B — each representing a milestone-driven increase in company valuation. Mager's approach to this process carries a specific caution: never try to raise all the capital you'll need at once.
The reason is dilution. If a company raises its entire projected capital requirement in the first round, the founder's ownership stake falls dramatically — and with it, the founder's incentive alignment and, in many cases, their effective control. Staged fundraising preserves founder ownership across the growth arc, and it ties each funding event to a demonstrated milestone rather than a projection.
What Valuation Actually Measures
The numbers investors focus on — revenue run rate, gross margin, burn rate — are necessary but not sufficient. Mager emphasizes that a figure like "$25M revenue run rate with 58% gross margin" tells you almost nothing by itself without understanding the manufacturing costs that produced it, the capital expenditure required to sustain it, and the competitive dynamics around it. Startup valuation is not a formula; it requires judgment alongside the math.
Stock Options: Aligning Incentives Across the Team
Stock options give employees the right to purchase shares at a predetermined price when the company succeeds. The design of this mechanism matters significantly for team motivation and retention. Mager's view is that one of the most important structural commitments a startup can make is ensuring that if the company wins, the people who built it share meaningfully in that outcome — not just the executives.
Silicon Valley norms on compensation create large gaps between executive and employee pay. Stock option programs, when designed carefully, narrow that gap if the company reaches its potential.
KPI Management
The metrics that matter vary by business type, but the principle is constant: know the numbers that indicate your company's health and trajectory, and review them with the same rigor as financial statements.
Relevant KPIs across startup types:
- Cash flow and burn rate (universal)
- Subscription renewal rate (SaaS and subscription models)
- Customer retention and churn
- Product development milestone completion
- Capital expenditure relative to plan
For a medical device company like Precision Neuroscience, manufacturing yields, FDA submission timelines, and clinical trial progression are all tracked as tightly as revenue.
Learning from Failure: The Supply Chain Lesson
When the Assumed Supply Chain Didn't Exist
Precision Neuroscience manufactures neural electrode arrays — fine-grained devices implanted near the brain surface. In the early development phase, Mager assumed that a supply chain capable of producing these components at the required specification already existed. It did not. Despite a seven-figure investment in vendor relationships, the company could not secure components that met its technical requirements.
The solution was to acquire a manufacturing facility in Texas and bring production in-house. That decision, made out of necessity, has since become one of the company's competitive advantages — control over its own manufacturing means control over quality and delivery timelines that competitors dependent on external vendors cannot guarantee.
The lesson Mager draws is characteristic of early-stage startup leadership: "dive in and learn as you go." The willingness to take on problems that have no established playbook, and to find solutions that didn't previously exist, is what distinguishes founders who build durable companies from those who don't.
FDA: Rigor as a Competitive Moat
For medical device companies, FDA approval is not optional. The path involves laboratory validation, clinical trials, regulatory submission, and review — a process that takes years and consumes significant capital. Mager frames the rigor of this process not as a burden but as a moat: companies that successfully navigate FDA validation have demonstrated a level of product quality and organizational competence that competitors who haven't gone through the process cannot easily replicate.
Summary
Michael Mager's experience at Precision Neuroscience distills into a set of operating principles that apply beyond medical devices:
- Hire for mission alignment first; skills are table stakes, conviction under pressure is the differentiator
- Build HR function from the beginning — it is not an administrative overhead, it is the foundation of company culture
- Avoid becoming a bottleneck; triage ruthlessly and delegate genuinely
- Stage your fundraising to preserve founder alignment and tie capital to milestones
- Understand that valuation numbers require context — manufacturing cost, capital intensity, and competitive position all matter
- Use stock options to align the full team with company success, not just executive leadership
- Know your KPIs cold and review them with the same seriousness as financial statements
- When the supply chain you need doesn't exist, build it — necessity has a way of becoming advantage
The arc of a startup from idea to durable company runs through failures that look, in retrospect, like expensive lessons. Mager's view is that the willingness to accumulate those lessons without being destroyed by them is the core competency of a founder. Everything else can be learned or hired for.
Reference: https://www.youtube.com/watch?v=Sh0NWZrsTtY
Related Articles
- The Reality of a Part-Time Employee Who Worked Full-Time, Took Two Maternity Leaves, and Changed Her View of Work | TIMEWELL
- Before Paternity Leave — What You Absolutely Must Do to Take Leave Even During a Busy Period
- Pursuing a Hands-On Architecture Firm: Finding My Own Way as the 5th Generation of a Construction Company | Fujita Construction
